I. P. Ashmarin, V. V. Gavryushov, V. Yu. Ionidi, et al., “Thyroliberin normalizes cerebral circulation and pO2
in neonates,” Dokl. Akad. Nauk SSSR
, No. 1, 214–244 (1990).Google Scholar
I. P. Ashmarin and M. F. Obukhova, “Regulatory peptides, a functionally continuous population,” Biokhimiya
, No. 4, 3–8 (1986).Google Scholar
I. P. Ashmarin and S. A. Chepurnov, “Thyroliberin, melanostatin, and their analogs - neurophysiological basis of expanded clinical use,” in: Neuroendicrinological Aspects of Current Endocrinology [in Russian], Moscow (1991), p. 7.
I. P. Ashmarin, I. E. Gurskaya, and A. A. Guseva, “Thyroliberin: new physiological effects and potential for clinical use,” Vestn. RAMN
, No. 6, 40–44 (1992).Google Scholar
I. P. Ashmarin, Neurophysiology
[in Russian], Institute of Biomedical Chemistry Press, Russian Academy of Medical Sciences, Moscow (1996).Google Scholar
I. P. Ashmarin, V. N. Nezavibatko, I. F. Myasoedov, A. A. Kamenskii, I. A. Grivenkov, M. A. Ponomareva-Stepnaya, L. A. Andreeva, A. Ya. Kaplan, V. B. Koshelev, and T. V. Ryasina, “The nootropic adrenocorticotropin 4-10 analog Semax. Fifteen years of experience in the development of studies,” Zh. Vyssh. Nerv. Deyat.
, No. 2, 420–429 (1997).Google Scholar
P. V. Balan, A. S. Maklakova, Ya. V. Krushinskaya, N. A. Sokolova, and Yu. B. Kudashov, “Delayed effects of acute hypobaric hypoxia in neonatal rats of different ages: the effects of the genopeptide Semax (ACTH4-7-PGP),” Akusherstvo i Ginekologiya, No. 1, 46–49 (1999).
N. A. Bastrikova, I. S. Novoderzhavina, A. A. Kamenskii, N. A. Sokolova, V. L. Kozhura, and I. P. Ashmarin, “The effects of hemorrhagic shock on learning processes in the delayed posthypoxic period,” Byull. Éksperim. Biol. Med.
, No. 12, 130–133 (1998).Google Scholar
E. O. Bragin and V. V. Yasentsov, “Opioid and monoamine mechanisms of regulation of body functions in extreme conditions,” in: Science and Technology [in Russian], All-Union Institute of Scientific and Technical Information (VINITI), Human and Animal Physiology Series (1991), Vol. 47.
I. G. Vlasova, N. E. Chepurnova, E. V. Efimova, S. A. Chepurnov, and I. P. Ashmarin, “Thyroliberin - long-lasting antihypoxic action,” Fiziol. Cheloveka
, No. 3, 107–109 (1994).Google Scholar
V. A. Voinov, N. I. Losev, and V. M. Bulaev, “The effects of naloxone and thyroliberin on respiration in conditions of acute hypoxia,” Byull. Éksperim. Biol. Med., No. 10, 408–410 (1984).
V. A. Voinov, N. I. Losev, and N. B. Romadanova, “Inspiratory stimulating effects of thyroliberin in conditions of acute respiratory hypoxia,” in: Proceedings of All-Union Scientific Conference, “Reactivity and Resistance. Fundamental and Applied Questions” [in Russian], Kiev (1987), p. 172.
E. N. Goncharenko, S. V. Antonova, S. V. Shestakova, M. Ya. Akhlaya, P. V. Balan, A. S. Maklakova, Ya. V. Krushinskaya, N. A. Sokolova, and I. P. Ashmarin, “Functional and biochemical characteristics of acute hypobaric hypoxia in neonatal and adult rats,” Akusherstvo i Ginekologiya, No. 3, 51–53 (1999).
V. A. Dubynin, N. Yu. Zemskaya, Yu. A. Ivleva, A. A. Kamenskii, S. V. Shestakova, I. V. Malinovskaya, E. N. Goncharenko, L. A. Andreeva, and N. F. Myasoedov, “Delayed effects of β-casomorphin-7 chronically administered to neonatal white rats,” Dokl. Ros. Akad. Nauk.
, No. 6, 839–842 (1999).Google Scholar
E. V. Efimova S. A. Cherpurnov, and N. E. Chepurnova, “Immediate and delayed effects of thyroliberin given intranasally to humans,” in: Principles and Mechanisms of Activity of the Human Brain [in Russian], Leningrad (1989), p. 248.
T. P. Zhukova, E. I. Znamenskaya, and N. G. Palenova, Structural Changes in the Brain. Perinatal Pathology
[in Russian], Meditsina, Moscow (1984).Google Scholar
V. Yu. Ionidi, A. B. Dulenkov, I. P. Ashmarin, S. A. Chepurnov, and N. E. Chepurnova, Thyroliberin - Antagonistic Actions and Normalization of Cerebral Circulation in the Clinical Resuscitation of Neonates. Collection of Reports
[in Russian], Moscow, Vo. 20, pp. 52–53 and 75-76 (1991).Google Scholar
V. B. Koshelev, I. Yu. Belov, and N. A. Sokolova, “Antihypoxic actions of a number of endogenous regulatory peptides,” in: Proceedings of Conference “Summaries and Perspectives” [in Russian], St. Petersburg (1994), No. 1, p. 51.
A. S. Maklakova, A. A. Kamenskii, L. A. Alfeeva, N. G. Levitskaya, N. F. Nezavibat'ko, and I. P. Ashmarin, “Behavioral effects of β-casomorphin-7 and its des-Tyr analogs,” Byull. Éksperim. Biol. Med.
, No. 8, 155–158 (1993).Google Scholar
A. S. Maklakova, A. A. Kamenskii, L. A. Alfeeva, I. V. Nazarenko, and N. F. Nezavibat'ko, “The effects of β-casomorphin-7 on the level of food-related and defensive motivation in different types of learning,” Zh. Vyssh. Nerv. Deyat.
, No. 6, 1143–1150 (1995).Google Scholar
A. S. Maklakova, The Neurotropic Effects of a Milk β-Casein Fragment, the Heptapeptide β-Casomorphin-7
[in Russian], Author's abstract of dissertation, Moscow State University Press, Moscow (1996).Google Scholar
M. V. Maslova, A. S. Maklakova A. V. Graf, N. A. Sokolova, I. P. Ashmarin, N. Yu. Kudryashova, Ya. V. Krushinskaya, E. N. Goncharenko, and S. V. Shestakova, “Brain bioamines and the behavior of offspring after antenatal hypoxia: effects of peptide neuromodulators,” Neirokhimiya (in press).
M. V. Maslova, A. S. Maklakova, M. V. Shkol'nikov, K. S. Zemlyanskii, and N. A. Sokolova, “The effects of prenatal acute hypobaric hypoxia on the behavioral responses of neonatal rats,” in: Fifth All-Russian Conference “Human Developmental Physiology,” Celebrating the 55th Anniversary from the Foundation of the Institute [in Russian], Moscow (2000), pp. 303–304.
M. A. Ponomareva-Stepnaya, V. N. Nezavibat'ko, L. V. Antonova, L. A. Andreeva, L. Yu. Alfeeva, V. N. Potamin, A. A. Kamenskii, and I. P. Ashmarin, “An analog of ACTH4-10
- a long-acting learning stimulator,” Khim. Farm. Zh.
, No. 7, 790–795 (1984).Google Scholar
Ts. V. Serbenyuk, I. E. Gurskaya, and A. D. Salyuta, “Restoration of impaired respiratory activity in cats by thyroliberin,” Byull. Éksperim. Biol. Med.
, No. 7, 17 (1990).Google Scholar
A. B. Sorokin, N. N. Zavadenko, A. S. Petrukhin, N. L. Gorbachevskaya, N. G. Manelis, N. V. Grigor'eva, and N. Yu. Suvorina, “Attention deficit with hyperactivity in children: results of a multidisciplinary study,” in: Proceedings of the First International Conference in Memory of A. R. Luriya [in Russian], Moscow (1997), p. 37.
É. A. Édel'shtein, Perinatal Hypoxic Neurological Syndromes
[in Russian], TsOLIUV Press, Moscow (1998).Google Scholar
I. P. Ashmarin, V. N. Nazavibatko, N. G. Levitskaya, V. B. Koshelev, and A. A. Kamensky, “Design and investigation of an ACTH(4-10) analogue lacking D-amino acids and hydrophobic radicals,” Neurosci. Res. Commun.
, No. 2, 105–112 (1995).Google Scholar
V. Brantl, H. Techemacher, A. Henschen, and F. Lottspeich, “Novel opioid peptides derived from casein (β-casomorphins). I. Isolation from bovine casein peptone,” Hoppe-Seyler's Z. Physiol. Chem.
, 1211–1216 (1979).Google Scholar
M. Dambska, D. Maslinska, and I. Kuchna, Neuropatol. Pol.
, No. 3-4, 245–253 (1992).Google Scholar
A. I. Faden, T. P. Jacobs, and J. W. Holaday, “Opiate antagonist in neurologic recovery after spinal injury,” Science
, 493–494 (1981).Google Scholar
A. I. Faden, T. P. Jacobs, and J. W. Holaday, “Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats,” New Eng. J. Med.
, 1063–1067 (1981).Google Scholar
M. T. Lin, H. K. Chan, C. F. Chen, and G. W. Teh, “Involvement of both opiate and catecholaminergic receptors in the behavioral excitation provoked by thryotropin-releasing hormone,” Neuropharmacol.
, 463–469 (1983).Google Scholar
L. Nordstrom and S. Arulkumaran, “Intrapartum fetal hypoxia and biochemical markers: a review,” Obstet. Gynecol. Surv.
, No. 10, 645–657 (1998).Google Scholar
C. Nyakas, B. Buwalda, R. J. Kramers, J. Traber, and P. G. Luiten, “Postnatal development of hippocampal and neocortical cholinergic and serotoninergic innervations in rat: effects of nitrite-induced prenatal hypoxia and nimodipine treatment,” Neurosci., 59, No. 3, (1994).
C. Nyakas, B. Buwalda, and P. G. Luiten, “Hypoxia and brain development,” Progr. Neurobiol.
, No. 1, 1–51 (1996).Google Scholar
A. Pasi, H. Mahler, N. Lansel, C. Bernasconi, and F. Messiha, “β-Casomorphin-imunoreactivity in the brain stem of the human infant,” Res. Commun. Chem. Pathol. Pharmacol.
, 305–322 (1993).Google Scholar
T. A. Slotkin, J. L. Saleh, E. C. McCook, and F. J. Seidler, “Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for sudden infant death syndrome,” Teratology
, No. 3, 177–184 (1997).Google Scholar
R. C. Vannucci, “Hypoxic-ischemic encephalopathy,” Amer. J. Perinatol.
, No. 3, 113–120 (2000).Google Scholar